Persistent nociception triggered by nerve growth factor (NGF) is mediated by TRPV1 and oxidative mechanisms

Journal of Neuroscience

Volumn 35, Issue 22, 2015, Pages 8593-8603

  Eskander, Michael A ^a   Ruparel, Shivani ^b   Green, Dustin P ^b   Chen, Paul B ^b   Por, Elaine D ^a   Jeske, Nathaniel A ^a,b   Gao, Xiaoli ^a   Flores, Eric R ^a   Hargreaves, Kenneth M ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Allodynia; Arachidonic acid; Hyperalgesia; Linoleic acid; Nerve growth factor; TRPV1

Indexed keywords

ANISOMYCIN; ARACHIDONIC ACID; CALCITONIN; CAPSAICIN; CYCLOHEXIMIDE; LINOLEIC ACID; NERVE GROWTH FACTOR; VANILLOID RECEPTOR 1; AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; CALCITONIN GENE RELATED PEPTIDE; PROTEIN SYNTHESIS INHIBITOR; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ADULT; ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVOKED RESPONSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERALGESIA; MALE; NOCICEPTION; NONHUMAN; OXIDATION; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; SKIN BIOPSY; SPINAL CORD; SPINAL GANGLION; THERMAL STIMULATION; WESTERN BLOTTING; ACTION POTENTIAL; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; INNERVATION; METABOLISM; OXIDATIVE STRESS; PAIN MEASUREMENT; PHYSIOLOGY; SENSORY NERVE CELL; SKIN; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; CELLS, CULTURED; CYCLOHEXIMIDE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GANGLIA, SPINAL; HYPERALGESIA; MALE; NERVE GROWTH FACTOR; NOCICEPTION; OXIDATIVE STRESS; PAIN MEASUREMENT; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SENSORY RECEPTOR CELLS; SENSORY SYSTEM AGENTS; SKIN; TRPV CATION CHANNELS;

EID: 84930422767     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3993-14.2015     Document Type: Article

References (55)

1. Aloe L, Tuveri MA, Carcassi U, Levi-Montalcini R (1992) Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis and Rheumatism 35:351–355.CrossRef Medline
2. Blandini F, Rinaldi L, Tassorelli C, Sances G, Motta M, Samuele A, Fancellu R, Nappi G, Leon A (2006) Peripheral levels of BDNF and NGF in primary headaches. Cephalalgia 26:136 –142.CrossRef Medline
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248 –254.CrossRef Medline
4. Bylund J, Ericsson J, Oliw EH (1998) Analysis of cytochrome P450 metabolites of arachidonic and linoleic acids by liquid chromatography-mass spectrometry with ion trap MS. Anal Biochem 265:55– 68.CrossRef Medline
5. Cattaneo A (2010) Tanezumab, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain. Curr Opin Mol Ther 12:94 –106.
6. Medline Cui M, Honore P, Zhong C, Gauvin D, Mikusa J, Hernandez G, Chandran P, Gomtsyan A, Brown B, Bayburt EK, Marsh K, Bianchi B, McDonald H, Niforatos W, Neelands TR, Moreland RB, Decker MW, Lee CH, Sullivan JP, Faltynek CR (2006) TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci 26:9385– 9393.CrossRef Medline
7. Delcroix JD, Valletta JS, Wu C, Hunt SJ, Kowal AS, Mobley WC (2003) NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals. Neuron 39:69–84.CrossRef Medline
8. Doly S, Fischer J, Conrath M (2004) The vanilloid receptor-1 (TRPV1) is expressed in some rat dorsal horn NK1 cells. Brain Res 1004:203–207.CrossRef Medline
9. Dupont R, Goossens JF, Cotelle N, Vrielynck L, Vezin H, Henichart JP, Cotelle P (2001) New bis-catechols 5-lipoxygenase inhibitors. Bioorganic and Medicinal Chemistry 9:229 –235.CrossRef Medline
10. Dyck PJ, Peroutka S, Rask C, Burton E, Baker MK, Lehman KA, Gillen DA, Hokanson JL, O’Brien PC (1997) Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology 48:501–505.CrossRef Medline
11. Fairbanks CA (2003) Spinal delivery of analgesics in experimental models of pain and analgesia. Adv Drug Deliv Rev 55:1007–1041.CrossRef Medline
12. Farooqui AA, Ong WY, Horrocks LA (2006) Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev 58: 591–620.CrossRef Medline
13. Gibbs JL, Flores CM, Hargreaves KM (2006) Attenuation of capsaicinevoked mechanical allodynia by peripheral neuropeptide Y Y1 receptors. Pain 124:167–174.CrossRef Medline
14. Goodman Y, Steiner MR, Steiner SM, Mattson MP (1994) Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res 654:171–176.CrossRef Medline
15. Green DP, Ruparel S, Roman L, Henry MA, Hargreaves KM (2013) Role of endogenous TRPV1 agonists in a postburn pain model of partialthickness injury. Pain 154:2512–2520.CrossRef Medline
16. Gregus AM, Doolen S, Dumlao DS, Buczynski MW, Takasusuki T, Fitzsimmons BL, Hua XY, Taylor BK, Dennis EA, Yaksh TL (2012) Spinal 12- lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors. Proc Natl Acad Sci U S A 109:6721– 6726.CrossRef Medline
17. Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988)Anew and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77– 88.CrossRef Medline
18. Hathway GJ, Fitzgerald M (2006) Time course and dose-dependence of nerve growth factor-induced secondary hyperalgesia in the mouse. J Pain 7:57– 61.
19. Medline Holzer P (2008) The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor. Br J Pharmacol 155:1145– 1162.CrossRef Medline
20. Honore P, Wismer CT, Mikusa J, Zhu CZ, Zhong C, Gauvin DM, Gomtsyan A, El Kouhen R, Lee CH, Marsh K, Sullivan JP, Faltynek CR, Jarvis MF (2005) A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. J Pharmacol Exp Ther 314:410–421.CrossRef Medline
21. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, Cho S, Min KH, Suh YG, Kim D, Oh U (2000) Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances. Proc Natl Acad Sci U S A 97:6155– 6160.CrossRef Medline
22. Iannone F, De Bari C, Dell’Accio F, Covelli M, Patella V, Lo Bianco G, Lapadula G (2002) Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140. TrkA) in human osteoarthritic chondrocytes. Rheumatology (Oxford) 41:1413–1418.CrossRef Medline
23. Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ (2002) p38.MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36:57– 68.CrossRef Medline
24. Kanai Y, Hara T, Imai A, Sakakibara A (2007) Differential involvement of TRPV1 receptors at the central and peripheral nerves in CFA-induced mechanical and thermal hyperalgesia. J Pharm Pharmacol 59:733–738.CrossRef Medline
25. Konkel A, Schunck WH (2011) Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids. Biochim Biophys Acta 1814: 210–222.CrossRef Medline
26. Lewin GR, Ritter AM, Mendell LM (1993) Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 13:2136 –2148.
27. Medline Lewin GR, Rueff A, Mendell LM (1994) Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci 6:1903–1912.CrossRef Medline
28. Lucas KK, Svensson CI, Hua XY, Yaksh TL, Dennis EA (2005) Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2. Br J Pharmacol 144:940 –952.CrossRef Medline
29. Malin S, Molliver D, Christianson JA, Schwartz ES, Cornuet P, Albers KM, Davis BM (2011) TRPV1 and TRPA1 function and modulation are target tissue dependent. J Neurosci 31:10516 –10528.CrossRef Medline
30. Mantyh PW, Koltzenburg M, Mendell LM, Tive L, Shelton DL (2011) Antagonism of nerve growth factor-TrkA signaling and the relief of pain. Anesthesiology 115:189 –204.CrossRef Medline
31. McGaraughty S, Chu KL, Brown BS, Zhu CZ, Zhong C, Joshi SK, Honore P, Faltynek CR, Jarvis MF (2008) Contributions of central and peripheral TRPV1 receptors to mechanically evoked and spontaneous firing of spinal neurons in inflamed rats. J Neurophysiol 100:3158 –3166.CrossRef Medline
32. Mills CD, Nguyen T, Tanga FY, Zhong C, Gauvin DM, Mikusa J, Gomez EJ, Salyers AK, Bannon AW (2013) Characterization of nerve growth factor-induced mechanical and thermal hypersensitivity in rats. Eur J Pain 17:469–479.CrossRef Medline
33. Nazıroglu M, Cig B, Ozgul C (2013) Neuroprotection induced by N-acetylcysteine against cytosolic glutathione depletion-induced Ca2 influx in dorsal root ganglion neurons of mice: role of TRPV1 channels. Neuroscience 242:151–160.CrossRef Medline
34. Nicol GD, Vasko MR (2007) Unraveling the story of NGF-mediated sensitization of nociceptive sensory neurons: ON or OFF the Trks? Mol Interv 7:26–41.CrossRef Medline
35. Paterson S, Schmelz M, McGlone F, Turner G, Rukwied R (2009) Facilitated neurotrophin release in sensitized human skin. Eur J Pain 13:399–405.CrossRef Medline
36. Patwardhan AM, Scotland PE, Akopian AN, Hargreaves KM (2009) Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia. Proc Natl Acad Sci U S A 106: 18820–18824.CrossRef Medline
37. Patwardhan AM, Akopian AN, Ruparel NB, Diogenes A, Weintraub ST, Uhlson C, Murphy RC, Hargreaves KM (2010) Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents. J Clin Invest 120:1617–1626.CrossRef Medline
38. Petty BG, Cornblath DR, Adornato BT, Chaudhry V, Flexner C, Wachsman M, Sinicropi D, Burton LE, Peroutka SJ (1994) The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 36:244 –246.CrossRef Medline
39. Rukwied R, Mayer A, Kluschina O, Obreja O, Schley M, Schmelz M (2010) NGF induces non-inflammatory localized and lasting mechanical and thermal hypersensitivity in human skin. Pain 148:407– 413.CrossRef Medline
40. Ruparel NB, Patwardhan AM, Akopian AN, Hargreaves KM (2008) Homologous and heterologous desensitization of capsaicin and mustard oil responses utilize different cellular pathways in nociceptors. Pain 135:271– 279.CrossRef Medline
41. Ruparel S, Green D, Chen P, Hargreaves KM (2012a) The cytochrome P450 inhibitor, ketoconazole, inhibits oxidized linoleic acid metabolitemediated peripheral inflammatory pain. Mol Pain 8:73.CrossRef Medline
42. Ruparel S, Henry MA, Akopian A, Patil M, Zeldin DC, Roman L, Hargreaves KM (2012b) Plasticity of cytochrome P450 isozyme expression in rat trigeminal ganglia neurons during inflammation. Pain 153:2031–2039.CrossRef Medline
43. Sarchielli P, Mancini ML, Floridi A, Coppola F, Rossi C, Nardi K, Acciarresi M, Pini LA, Calabresi P (2007) Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain 8:737–745.CrossRef Medline
44. Svensson CI, Yaksh TL (2002) The spinal phospholipase-cyclooxygenaseprostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 42:553–583.CrossRef Medline
45. Svensson P, Cairns BE, Wang K, Arendt-Nielsen L (2003) Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia. Pain 104:241–247.CrossRef Medline
46. Tria MA, Fusco M, Vantini G, Mariot R (1994) Pharmacokinetics of nerve growth factor (NGF) following different routes of administration to adult rats. Exp Neurol 127:178 –183.CrossRef Medline
47. Wen H, Ostman J, Bubb KJ, Panayiotou C, Priestley JV, Baker MD, Ahluwalia A (2012) 20-Hydroxyeicosatetraenoic acid (20-HETE) is a novel activator of transient receptor potential vanilloid 1 (TRPV1) channel. J Biol Chem 287:13868 –13876.CrossRef Medline
48. Willis WD Jr (2009) The role of TRPV1 receptors in pain evoked by noxious thermal and chemical stimuli. Exp Brain Res 196:5–11.CrossRef Medline
49. Woolf CJ (1996) Phenotypic modification of primary sensory neurons: The role of nerve growth factor in the production of persistent pain. Philosophical Transactions of the Royal Society of London Series B, Biological Sciences 351:441– 448.CrossRef Medline
50. Woolf CJ, Ma QP, Allchorne A, Poole S (1996) Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J Neurosci 16:2716 –2723.
51. Medline Yaksh TL, Farb DH, Leeman SE, Jessell TM (1979) Intrathecal capsaicin depletes substance P in the rat spinal cord and produces prolonged thermal analgesia. Science 206:481– 483.CrossRef Medline
52. Zhou HY, Chen SR, Chen H, Pan HL (2009) The glutamatergic nature of TRPV1-expressing neurons in the spinal dorsal horn. J Neurochem 108: 305–318.CrossRef Medline
53. Zhu W, Oxford GS (2007) Phosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1. Mol Cell Neurosci 34:689 –700.CrossRef Medline
54. Zhu W, Oxford GS (2011) Differential gene expression of neonatal and adultDRGneurons correlates with the differential sensitization of TRPV1 responses to nerve growth factor. Neurosci Lett 500:192–196.CrossRef Medline
55. Zhu W, Galoyan SM, Petruska JC, Oxford GS, Mendell LM (2004) A developmental switch in acute sensitization of small dorsal root ganglion (DRG) neurons to capsaicin or noxious heating by NGF. J Neurophysiol 92:3148 –3152.CrossRef Medline